Cencora Inc.(COR),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

COR Cencora Inc.

Trading 11-22 11:43:19 EST

245.87

+0.18

+0.07%

High247.55	Low245.20	Vol250.97K
Open245.20	D1 Closing245.69	Amplitude0.96%
Mkt Cap48.19B	Tradable Cap43.08B	Total Shares196.01M
T/O61.80M	T/O Rate0.14%	Tradable Shares175.20M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

{"stockData":{"symbol":"COR","market":"US","secType":"STK","nameCN":"Cencora Inc.","latestPrice":245.87,"timestamp":1732293797361,"preClose":245.69,"halted":0,"volume":250972,"delay":0,"floatShares":175198242,"shares":196007584,"eps":7.53,"marketStatus":"Trading","change":0.18,"latestTime":"11-22 11:43:19 EST","open":245.2,"high":247.55,"low":245.2,"amount":61802683.2076,"amplitude":0.009565,"askPrice":245.95,"askSize":3,"bidPrice":245.79,"bidSize":100,"shortable":3,"etf":0,"ttmEps":7.53,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Market Trading","tradingStatus":3,"beginTime":1732309200000},"marketStatusCode":2,"adr":0,"adrRate":0,"listingDate":1285214400000,"exchange":"NYSE","adjPreClose":245.69,"dividendRate":0.008297,"preHourTrading":{"tag":"盘前","latestPrice":246.57,"preClose":245.69,"latestTime":"09:13 EST","volume":1092,"amount":267396.5658,"timestamp":1732284783331},"postHourTrading":{"tag":"盘后","latestPrice":245.31,"preClose":245.69,"latestTime":"19:36 EST","volume":47044,"amount":11557754.66,"timestamp":1732235816620},"volumeRatio":0.640981,"impliedVol":0.1959,"impliedVolPercentile":0.3571},"requestUrl":"/m/hq/s/COR/tweets","defaultTab":"tweets","newsList":[{"id":"2485742983","title":"Cencora Inc. Stock Outperforms Competitors On Strong Trading Day","url":"https://stock-news.laohu8.com/highlight/detail?id=2485742983","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2485742983?lang=en_us&edition=fundamental","pubTime":"2024-11-22 05:53","pubTimestamp":1732225980,"startTime":"0","endTime":"0","summary":"This article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Cencora Inc.  rallied 1.02% to $245.69 Thursday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500 Index  rising 0.53% to 5,948.71 and the Dow Jones Industrial Average  rising 1.06% to 43,870.35.This was the stock's second consecutive day of gains.Cencora Inc. closed $5.87 below its 52-week high , which the company achieved on November 12th.The stock outperformed some of its competitors Thursday, as Amazon.com Inc.  fell 2.22% to $198.38, UnitedHealth Group Inc.  fell 0.50% to $597.49, and CVS Health Corp.  rose 0.48% to $57.10.Trading volume  remained 539,566 below its 50-day average volume of 1.5 M.Data source: Dow Jones Market Data, FactSet. Data compiled November 21, 2024.This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Stre","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["COR"],"gpt_icon":0},{"id":"2485445191","title":"MCK Stock Down Despite Latest Partnership to Boost SCD Treatment","url":"https://stock-news.laohu8.com/highlight/detail?id=2485445191","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2485445191?lang=en_us&edition=fundamental","pubTime":"2024-11-22 00:28","pubTimestamp":1732206480,"startTime":"0","endTime":"0","summary":"McKesson Corporation’s MCK dedicated business focused on supporting the commercialization of cell and gene therapies, InspiroGene, has been selected by Vertex Pharmaceuticals Incorporated VRTX to expand commercial distribution options for CASGEVY. InspiroGene will partner with Vertex to expand distribution options for CASGEVY.CASGEVY , the first CRISPR-based gene-editing therapy approved by the FDA, is indicated for the treatment of patients 12 years and above with sickle cell disease  with recurrent vaso-occlusive crises or transfusion-dependent β-thalassemia.The availability of the FDA-approved drug is expected to significantly solidify McKesson’s foothold in the SCD treatment space.Following the announcement on Nov. 14, shares of the company lost nearly 0.6% till yesterday.This month, McKesson’s oncology technology and insights business, Ontada, announced a strategic collaboration with health data platform, Datavant, to include Ontada’s data in their health ecosystem. The collaborat","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/x7AJ0AkRL_CYuqXFyPb2BQ--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/c8704ffaba0234da981fa842a48f77b5","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/x7AJ0AkRL_CYuqXFyPb2BQ--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/c8704ffaba0234da981fa842a48f77b5"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/mck-stock-down-despite-latest-162800618.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4588","LU0109394709.USD","MCK","LU0251142724.SGD","LU1814569148.SGD","IE00B4R5TH58.HKD","LU0889566641.SGD","LU2462157665.USD","LU0889565916.HKD","VERX","LU0251131958.USD","LU1934455194.USD","LU0823416689.USD","IE00BJJMRZ35.SGD","LU1057294990.SGD","SGXZ23171101.USD","LU2362540622.SGD","IE00B19Z9Z06.USD","LU1093756168.USD","CAH","LU0128525689.USD","LU0234570918.USD","LU1934455863.HKD","LU1880398471.USD","SG9999004303.SGD","IE00B19Z3B42.SGD","IE00B2B36J28.USD","BK4529","LU0058720904.USD","LU2417539215.USD","SCD","BK4023","LU1037948541.HKD","LU0079474960.USD","LU0417517546.SGD","LU1430594728.SGD","LU0310799852.SGD","LU1934455277.USD","LU2456880835.USD","LU0310800965.SGD","IE0009355771.USD","BK4084","BK4585","LU2362541273.HKD","BK4175","LU0122379950.USD","VRTX","LU0211327993.USD","LU1571399168.USD","COR"],"gpt_icon":0},{"id":"2484920656","title":"Patterson Companies Stock Up Following Latest Partnership Extension","url":"https://stock-news.laohu8.com/highlight/detail?id=2484920656","media":"Zacks","labels":["Company Corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2484920656?lang=en_us&edition=fundamental","pubTime":"2024-11-19 22:54","pubTimestamp":1732028040,"startTime":"0","endTime":"0","summary":"PDS Health, earlier known as Pacific Dental Services, is a renowned dental and medical support organization that delivers services across the United States.The latest announcement is expected to significantly boost Patterson Companies’ Dental business unit.Historically, the company has gained a high level of synergies from its various partnerships. We expect market sentiment on the stock to continue to remain positive around this announcement, too.Patterson Companies currently has a market capitalization of $1.84 billion. It has an earnings yield of 11.1%, higher than the industry’s 5.3%. In the last reported quarter, PDCO delivered a negative earnings surprise of 25%.In July, Patterson Companies’ Patterson Dental Supply announced a new Eaglesoft native integration with Pearl Second Opinion. The new integration within Eaglesoft Advanced Imaging adds Pearl Second Opinion real-time clinical detections directly to x-rays captured and presented in Eaglesoft.","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/x7AJ0AkRL_CYuqXFyPb2BQ--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/c8704ffaba0234da981fa842a48f77b5","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/x7AJ0AkRL_CYuqXFyPb2BQ--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/c8704ffaba0234da981fa842a48f77b5"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/patterson-companies-stock-following-latest-145400997.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"Company Corporation","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU0211327993.USD","LU0006061336.USD","LU0310800965.SGD","SGXZ23171101.USD","LU0072461881.USD","BK4585","LU0128525689.USD","LU1267930490.SGD","COR","LU1119994496.HKD","CAH","LU0289739699.SGD","LU1261432733.SGD","LU0310799852.SGD","LU0792757196.USD","BK4588","BK4529","LU2065732104.USD","LU1084165304.USD","BK4082","LU1267930227.SGD","SG9999001440.SGD","LU1571399168.USD","PDCO","LU0889566641.SGD","LU2324357040.USD","LU1585245621.USD","BK4084","LU1430594728.SGD","LU1267930813.SGD","LU0058720904.USD","LU0211328371.USD","LU0052756011.USD","SG9999004303.SGD","BK4567","BK4175","GMED","LU0162691827.USD","IE0009354923.USD","LU1880398554.USD","LU1880398471.USD"],"gpt_icon":0},{"id":"2484992481","title":"Are Medical Stocks Lagging  Cencora, Inc. (COR) This Year?","url":"https://stock-news.laohu8.com/highlight/detail?id=2484992481","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2484992481?lang=en_us&edition=fundamental","pubTime":"2024-11-19 22:40","pubTimestamp":1732027213,"startTime":"0","endTime":"0","summary":"For those looking to find strong Medical stocks, it is prudent to search for companies in the group that are outperforming their peers. Is Cencora  one of those stocks right now?By taking a look at the stock's year-to-date performance in comparison to its Medical peers, we might be able to answer that question.Cencora is a member of our Medical group, which includes 1023 different companies and currently sits at #3 in the Zacks Sector Rank. The Zacks Sector Rank gauges the strength of our 16 individual sector groups by measuring the average Zacks Rank of the individual stocks within the groups.The Zacks Rank emphasizes earnings estimates and estimate revisions to find stocks with improving earnings outlooks. This system has a long record of success, and these stocks tend to be on track to beat the market over the next one to three months. Cencora is currently sporting a Zacks Rank of #2 .According to our latest data, COR has moved about 18.3% on a year-to-date basis. At the same time, ","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/UACuRym2G7Sc_7yqOtSLVQ--~B/aD0yMzUxO3c9MzAwMDthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/zacks.com/c65fb4556b91b6c9dc83e4eff25fede0","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/UACuRym2G7Sc_7yqOtSLVQ--~B/aD0yMzUxO3c9MzAwMDthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/zacks.com/c65fb4556b91b6c9dc83e4eff25fede0"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/medical-stocks-lagging-cencora-inc-144013209.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4084","BK4585","LU0053671581.USD","LU0289739699.SGD","BK4175","LU0058720904.USD","LU1585245621.USD","LU2324357040.USD","HALO","LU1084165304.USD","SGXZ23171101.USD","LU1261432733.SGD","LU1119994496.HKD","LU1430594728.SGD","BK4588","COR","BK4529","SG9999004303.SGD","BK4139"],"gpt_icon":0},{"id":"2484394868","title":"Cencora (COR) Receives a Buy from J.P. Morgan","url":"https://stock-news.laohu8.com/highlight/detail?id=2484394868","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2484394868?lang=en_us&edition=fundamental","pubTime":"2024-11-19 20:07","pubTimestamp":1732018044,"startTime":"0","endTime":"0","summary":"In a report released yesterday, Lisa Gill from J.P. Morgan maintained a Buy rating on Cencora (COR – Research Report), with a price target of $289....","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/cencora-cor-receives-a-buy-from-j-p-morgan?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/cencora-cor-receives-a-buy-from-j-p-morgan?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4516","LU0098860793.USD","LU1989772840.SGD","LU1074936037.SGD","LU0006306889.USD","BK4588","LU0225283273.USD","LU0106261372.USD","LU0267386448.USD","LU0314104364.USD","LU1430594728.SGD","LU0289739699.SGD","LU0106831901.USD","BK4504","LU1720051108.HKD","COR","LU1989772923.USD","LU1548497426.USD","BK4581","LU0971096721.USD","LU1363072403.SGD","SGXZ23171101.USD","BK4529","LU1668664300.SGD","LU2357305700.SGD","LU1585245621.USD","BK4127","IE00BZ1G4Q59.USD","LU1162221912.USD","LU1119994496.HKD","IE00BKVL7J92.USD","BK4175","LU0058720904.USD","LU2324357040.USD","LU0320765646.SGD","BK4084","LU1720051017.SGD","BK4534","LU1084165304.USD","SG9999004303.SGD","BK4585","LU1261432733.SGD"],"gpt_icon":0},{"id":"2484912429","title":"JPMorgan Adjusts Price Target on Cencora to $289 From $287, Maintains Overweight Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2484912429","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2484912429?lang=en_us&edition=fundamental","pubTime":"2024-11-19 19:32","pubTimestamp":1732015972,"startTime":"0","endTime":"0","summary":"Cencora (COR) has an average rating of overweight and mean price target of $272.13, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from major bank","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["COR"],"gpt_icon":0},{"id":"2484984700","title":"Cencora Inc. Stock Outperforms Competitors On Strong Trading Day","url":"https://stock-news.laohu8.com/highlight/detail?id=2484984700","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2484984700?lang=en_us&edition=fundamental","pubTime":"2024-11-19 05:53","pubTimestamp":1731966780,"startTime":"0","endTime":"0","summary":"This article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Cencora Inc.  rose 1.09% to $242.87 Monday, on what proved to be an all-around mixed trading session for the stock market, with the S&P 500 Index  rising 0.39% to 5,893.62 and the Dow Jones Industrial Average  falling 0.13% to 43,389.60.The stock's rise snapped a two-day losing streak.Cencora Inc. closed $8.69 below its 52-week high , which the company reached on November 12th.The stock demonstrated a mixed performance when compared to some of its competitors Monday, as Amazon.com Inc.  fell 0.45% to $201.70, UnitedHealth Group Inc.  fell 0.44% to $589.65, and CVS Health Corp.  rose 5.38% to $56.05.Trading volume  remained 308,356 below its 50-day average volume of 1.6 M.Data source: Dow Jones Market Data, FactSet. Data compiled November 18, 2024.This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones News","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["COR"],"gpt_icon":0},{"id":"2484460478","title":"EXCLUSIVE-Activist investor Ananym Capital pushes for changes at Henry Schein, sources say","url":"https://stock-news.laohu8.com/highlight/detail?id=2484460478","media":"Reuters","labels":["Executive Changes","event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2484460478?lang=en_us&edition=fundamental","pubTime":"2024-11-19 02:30","pubTimestamp":1731954622,"startTime":"0","endTime":"0","summary":"EXCLUSIVE-Activist investor Ananym Capital pushes for changes at Henry Schein, sources sayAnanym Capital urges board changes, CEO succession plan, cost cutsAnanym says medical distribution business sa","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241118:nL1N3MP0P7:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"Executive Changes,event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1066053197.SGD","LU0788109394.HKD","LU1718418525.SGD","BK4592","LU0122379950.USD","LU2468319806.SGD","LU0300736492.USD","LU0612318971.USD","LU0965509283.SGD","LU0122376428.USD","XOM","LU1934455863.HKD","LU1061106388.HKD","LU0965509010.AUD","LU0742534661.SGD","BK4175","HSIC","SG9999014567.USD","BK4570","LU1267930813.SGD","LU0792757196.USD","BK4533","BK4585","LU1582986433.USD","LU1074936037.SGD","SG9999015341.SGD","LU0251131958.USD","LU0203347892.USD","LU0433182093.SGD","SG9999002224.SGD","BK4516","LU0170899867.USD","LU1057294990.SGD","LU2133065610.SGD","SG9999014542.SGD","LU1489326972.SGD","LU0068578508.USD","MCK","LU0912757837.SGD","COR","LU1430594728.SGD","LU1934455194.USD","LU1983260115.SGD","LU0203345920.USD","BK4534","LU0861579265.USD","LU1066051498.USD","BK4201","LU0795875086.SGD","LU0868494708.USD"],"gpt_icon":0},{"id":"2483536806","title":"Cencora Inc. Stock Outperforms Competitors Despite Losses On The Day","url":"https://stock-news.laohu8.com/highlight/detail?id=2483536806","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483536806?lang=en_us&edition=fundamental","pubTime":"2024-11-16 05:53","pubTimestamp":1731707580,"startTime":"0","endTime":"0","summary":"This article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Cencora Inc.  shed 1.08% to $240.24 Friday, on what proved to be an all-around poor trading session for the stock market, with the S&P 500 Index  falling 1.32% to 5,870.62 and Dow Jones Industrial Average  falling 0.70% to 43,444.99.This was the stock's second consecutive day of losses.Cencora Inc. closed $11.32 below its 52-week high , which the company reached on November 12th.The stock demonstrated a mixed performance when compared to some of its competitors Friday, as Amazon.com Inc.  fell 4.19% to $202.61, UnitedHealth Group Inc.  fell 0.16% to $592.23, and CVS Health Corp.  fell 3.45% to $53.19.Trading volume  eclipsed its 50-day average volume of 1.6 M.Data source: Dow Jones Market Data, FactSet. Data compiled November 15, 2024.This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and Th","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["COR"],"gpt_icon":0},{"id":"2483865489","title":"Cencora Inc. Stock Underperforms Wednesday When Compared To Competitors Despite Daily Gains","url":"https://stock-news.laohu8.com/highlight/detail?id=2483865489","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483865489?lang=en_us&edition=fundamental","pubTime":"2024-11-14 05:53","pubTimestamp":1731534780,"startTime":"0","endTime":"0","summary":"This article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Cencora Inc.  inched 0.47% higher to $249.97 Wednesday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500 Index  rising 0.02% to 5,985.38 and the Dow Jones Industrial Average  rising 0.11% to 43,958.19.Cencora Inc. closed $1.59 short of its 52-week high , which the company reached on November 12th.The stock demonstrated a mixed performance when compared to some of its competitors Wednesday, as Amazon.com Inc.  rose 2.48% to $214.10, UnitedHealth Group Inc.  fell 1.43% to $605.87, and CVS Health Corp.  rose 0.44% to $54.27.Trading volume  remained 341,571 below its 50-day average volume of 1.6 M.Data source: Dow Jones Market Data, FactSet. Data compiled November 13, 2024.This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Jo","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["COR"],"gpt_icon":0},{"id":"2483855816","title":"Market Chatter: Baltimore Wins $266 Million in Lawsuit Against Opioid Distributors","url":"https://stock-news.laohu8.com/highlight/detail?id=2483855816","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483855816?lang=en_us&edition=fundamental","pubTime":"2024-11-14 02:42","pubTimestamp":1731523373,"startTime":"0","endTime":"0","summary":"The City of Baltimore was awarded $266 million in a lawsuit accusing McKesson  and Cencora  of enabling an opioid-addiction epidemic in the US, Reuters reported Wednesday.McKesson and Cencora did not immediately reply to requests for comment from MT Newswires.Price: 626.84, Change: +9.18, Percent Change: +1.49","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4533","LU0251131958.USD","LU1983260115.SGD","LU0048573561.USD","SG9999004303.SGD","LU0861579265.USD","LU0868494708.USD","LU0868494617.USD","LU1119994496.HKD","LU1061106388.HKD","LU1084165304.USD","LU2468319806.SGD","SGXZ23171101.USD","LU1430594728.SGD","LU1057294990.SGD","MCK","LU1585245621.USD","LU1934455863.HKD","BK4585","LU2324357040.USD","LU0058720904.USD","LU2112291526.USD","LU0942090050.USD","LU1934455194.USD","LU1814569148.SGD","LU1037948897.HKD","BK4588","LU0965509101.SGD","BK4175","LU0122379950.USD","COR","LU0965508806.USD","LU1934455277.USD","LU1023059063.AUD","BK4084","LU0965509283.SGD","LU2089984988.USD","LU0251142724.SGD","LU0742534661.SGD","BK4529","LU1037948541.HKD","LU0289739699.SGD","LU0965509010.AUD","LU1261432733.SGD"],"gpt_icon":0},{"id":"2483853177","title":"Baltimore Wins $266 Million in Lawsuit Against Opioid Distributors, Reuters Reports","url":"https://stock-news.laohu8.com/highlight/detail?id=2483853177","media":"MT Newswires Live","labels":["Policy And Regulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483853177?lang=en_us&edition=fundamental","pubTime":"2024-11-14 02:36","pubTimestamp":1731522982,"startTime":"0","endTime":"0","summary":"Price: 627.22, Change: +9.56, Percent Change: +1.55","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"Policy And Regulatory","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU0942090050.USD","LU2112291526.USD","SG9999004303.SGD","LU2468319806.SGD","LU0965509010.AUD","LU0251142724.SGD","LU0868494708.USD","LU0048573561.USD","BK4588","LU1934455277.USD","LU1585245621.USD","BK4084","LU1119994496.HKD","BK4533","SGXZ23171101.USD","LU1814569148.SGD","BK4175","LU0058720904.USD","LU0251131958.USD","LU2089984988.USD","LU0742534661.SGD","BK4529","LU1061106388.HKD","MCK","LU1037948541.HKD","LU1261432733.SGD","LU0122379950.USD","LU0965509283.SGD","LU0965509101.SGD","LU1983260115.SGD","LU1037948897.HKD","LU1934455863.HKD","LU1023059063.AUD","LU2324357040.USD","LU0868494617.USD","LU1084165304.USD","LU1430594728.SGD","COR","LU1934455194.USD","LU0289739699.SGD","LU0861579265.USD","LU1057294990.SGD","LU0965508806.USD","BK4585"],"gpt_icon":0},{"id":"2483839768","title":"Baltimore wins $266 million in opioid case against distributors","url":"https://stock-news.laohu8.com/highlight/detail?id=2483839768","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483839768?lang=en_us&edition=fundamental","pubTime":"2024-11-14 00:50","pubTimestamp":1731516607,"startTime":"0","endTime":"0","summary":"By Brendan Pierson      Nov 13 (Reuters) - The city of Baltimore won $266 million in its lawsuit accusing  top drug distributors McKesson  and Cencora    of fueling an epidemic of opioid addiction in ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1023059063.AUD","BK4585","LU1934455277.USD","LU1037948897.HKD","BK4588","LU0742534661.SGD","LU1119994496.HKD","LU1983260115.SGD","LU1057294990.SGD","SG9999004303.SGD","LU2468319806.SGD","LU1585245621.USD","LU0058720904.USD","LU1261432733.SGD","LU0048573561.USD","SGXZ23171101.USD","LU0251131958.USD","LU0289739699.SGD","LU1430594728.SGD","BK4533","LU2112291526.USD","LU0965509010.AUD","LU1814569148.SGD","LU1934455194.USD","LU1037948541.HKD","LU1084165304.USD","LU1934455863.HKD","MCK","LU0868494708.USD","LU0251142724.SGD","BK4084","BK4529","LU0942090050.USD","LU0965509101.SGD","LU0965509283.SGD","LU0965508806.USD","COR","LU2324357040.USD","LU0868494617.USD","LU0122379950.USD","LU1061106388.HKD","LU0861579265.USD","LU2089984988.USD","BK4175"],"gpt_icon":0},{"id":"2483891836","title":"Here's Why Cencora (COR) is a Strong Growth Stock","url":"https://stock-news.laohu8.com/highlight/detail?id=2483891836","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483891836?lang=en_us&edition=fundamental","pubTime":"2024-11-13 22:45","pubTimestamp":1731509111,"startTime":"0","endTime":"0","summary":"It doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors.Many investors also have a go-to methodology that helps guide their buy and sell decisions. One way to find winning stocks based on your preferred way of investing is to use the Zacks Style Scores, which are indicators that rate stocks based on three widely-followed investing types: value, growth, and momentum.Why This 1 Growth Stock Should Be On Your Watchlist. Different than value or momentum investors, growth-oriented investors are concerned with a stock's future prospects, and the overall financial health and strength of a company. Thus, they'll want to focus on the Growth Style Score, which analyzes characteristics like projected and historical earnings, sales, and cash flow to find stocks that will see sustainable growth over time.Three analysts revised their earnings estimate upwards in the last 60 days, and the Zacks Consensus Esti","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/26ddEdIk.0DefsBmi91u3Q--~B/aD01OTg7dz05MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/21b1f011539d3e31c28282071d344177","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/26ddEdIk.0DefsBmi91u3Q--~B/aD01OTg7dz05MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/21b1f011539d3e31c28282071d344177"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/heres-why-cencora-cor-strong-144511905.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU0058720904.USD","BK4175","LU1119994496.HKD","LU1585245621.USD","BK4084","LU2324357040.USD","LU1084165304.USD","LU1430594728.SGD","BK4588","LU0289739699.SGD","BK4585","SGXZ23171101.USD","BK4529","COR","SG9999004303.SGD","LU1261432733.SGD"],"gpt_icon":0},{"id":"2483836508","title":"Cencora, Inc. (COR) Hits Fresh High: Is There Still Room to Run?","url":"https://stock-news.laohu8.com/highlight/detail?id=2483836508","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483836508?lang=en_us&edition=fundamental","pubTime":"2024-11-13 22:15","pubTimestamp":1731507305,"startTime":"0","endTime":"0","summary":"Have you been paying attention to shares of Cencora ?Shares have been on the move with the stock up 6.7% over the past month. The stock hit a new 52-week high of $251.56 in the previous session. Cencora has gained 21.1% since the start of the year compared to the 3.1% move for the Zacks Medical sector and the -5.2% return for the Zacks Medical Services industry.The stock has an impressive record of positive earnings surprises, as it hasn't missed our earnings consensus estimate in any of the last four quarters. In its last earnings report on November 6, 2024, Cencora reported EPS of $3.34 versus consensus estimate of $3.21 while it beat the consensus revenue estimate by 1.76%.For the current fiscal year, Cencora is expected to post earnings of $14.88 per share on $315.26 billion in revenues. This represents an 8.14% change in EPS on a 7.25% change in revenues. For the next fiscal year, the company is expected to earn $16.29 per share on $336.52 billion in revenues. This represents a ye","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/OL7xfT5pzuzwP2wxb1pcSw--~B/aD02MjU7dz05MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/7ea641b46fe75c0a913349e5e610d6a2","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/OL7xfT5pzuzwP2wxb1pcSw--~B/aD02MjU7dz05MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/7ea641b46fe75c0a913349e5e610d6a2"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/cencora-inc-cor-hits-fresh-141505392.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4529","LU1169589451.USD","COR","LU1261432733.SGD","LU1119994496.HKD","BK4175","BK4154","LU1430594728.SGD","LU2065731478.USD","LU0058720904.USD","BK4084","LU1169590202.USD","LU0289739699.SGD","SG9999004303.SGD","SGXZ23171101.USD","LU1084165304.USD","BK4588","HQY","LU1585245621.USD","LU2324357040.USD","BK4585"],"gpt_icon":0},{"id":"2482333761","title":"Cencora Inc. Stock Outperforms Competitors On Strong Trading Day","url":"https://stock-news.laohu8.com/highlight/detail?id=2482333761","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2482333761?lang=en_us&edition=fundamental","pubTime":"2024-11-12 05:53","pubTimestamp":1731361980,"startTime":"0","endTime":"0","summary":"This article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Cencora Inc.  inched 0.27% higher to $249.09 Monday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500 Index  rising 0.10% to 6,001.35 and the Dow Jones Industrial Average  rising 0.69% to 44,293.13.This was the stock's fifth consecutive day of gains.Cencora Inc. closed $1.91 short of its 52-week high , which the company achieved on November 8th.The stock demonstrated a mixed performance when compared to some of its competitors Monday, as Amazon.com Inc.  fell 0.64% to $206.84, UnitedHealth Group Inc.  rose 1.53% to $625.25, and CVS Health Corp.  rose 0.49% to $55.81.Trading volume  remained 337,254 below its 50-day average volume of 1.6 M.Data source: Dow Jones Market Data, FactSet. Data compiled November 11, 2024.This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently fr","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["COR"],"gpt_icon":0},{"id":"2482751703","title":"Cencora Full Year 2024 Earnings: EPS Misses Expectations","url":"https://stock-news.laohu8.com/highlight/detail?id=2482751703","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2482751703?lang=en_us&edition=fundamental","pubTime":"2024-11-12 02:13","pubTimestamp":1731348786,"startTime":"0","endTime":"0","summary":"NYSE:COR Revenue and Expenses Breakdown November 11th 2024. All figures shown in the chart above are for the trailing 12 month  period. Revenue was in line with analyst estimates. Earnings per share  missed analyst estimates by 27%.The primary driver behind last 12 months revenue was the U.S. Healthcare Solutions segment contributing a total revenue of US$265.3b . Notably, cost of sales worth US$284.0b amounted to 97% of total revenue thereby underscoring the impact on earnings. The largest operating expense was General & Administrative costs, amounting to US$5.66b . Explore how COR's revenue and expenses shape its earnings.Looking ahead, revenue is forecast to grow 6.2% p.a. on average during the next 3 years, compared to a 6.7% growth forecast for the Healthcare industry in the US.The company's shares are up 6.0% from a week ago.You still need to take note of risks, for example - Cencora has   2 warning signs   we think you should be aware of.","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/5Vpve0Pc2F3m_L3fs2p_dQ--~B/aD02MzY7dz05NDU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/simply_wall_st__316/78a8c60a6283aea0450523395306d38c","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/5Vpve0Pc2F3m_L3fs2p_dQ--~B/aD02MzY7dz05NDU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/simply_wall_st__316/78a8c60a6283aea0450523395306d38c"],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/cencora-full-2024-earnings-eps-181306155.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["COR"],"gpt_icon":0},{"id":"2482730176","title":"TD Cowen Adjusts Price Target on Cencora to $288 From $263, Keeps Buy Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2482730176","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2482730176?lang=en_us&edition=fundamental","pubTime":"2024-11-12 01:03","pubTimestamp":1731344617,"startTime":"0","endTime":"0","summary":"Cencora (COR) has an average rating of outperform and price targets ranging from $230 to $292, according to analysts polled by Capital IQ.(MT Newswires covers equity, commodity and economic research f","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate","earning"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["COR","COWN","TD"],"gpt_icon":0},{"id":"2482373754","title":"Why Cencora (COR) is a Top Momentum Stock for the Long-Term","url":"https://stock-news.laohu8.com/highlight/detail?id=2482373754","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2482373754?lang=en_us&edition=fundamental","pubTime":"2024-11-11 22:50","pubTimestamp":1731336612,"startTime":"0","endTime":"0","summary":"For new and old investors, taking full advantage of the stock market and investing with confidence are common goals.Achieving those goals is made easier with the Zacks Style Scores, a unique set of guidelines that rates stocks based on popular investing methodologies, namely value, growth, and momentum. The Style Scores can help you narrow down which stocks are better for your portfolio and which ones can beat the market over the long-term.Is This 1 Momentum Stock a Screaming Buy Right Now?Momentum investors, who live by the saying \"the trend is your friend,\" are most interested in taking advantage of upward or downward trends in a stock's price or earnings outlook. Utilizing one-week price change and the monthly percentage change in earnings estimates, among other factors, the Momentum Style Score can help determine favorable times to buy high-momentum stocks.A company's earnings performance is important for momentum investors as well. For fiscal 2025, three analysts revised their ear","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/d6hN0_BhikrNdWTnix6fng--~B/aD03NDE7dz05MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/7853de8d69faeccb7d1ad6ebba40b8a2","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/d6hN0_BhikrNdWTnix6fng--~B/aD03NDE7dz05MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/7853de8d69faeccb7d1ad6ebba40b8a2"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/why-cencora-cor-top-momentum-145012661.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4175","COR","LU1585245621.USD","LU0289739699.SGD","BK4588","BK4529","LU1261432733.SGD","LU1430594728.SGD","LU1084165304.USD","LU0058720904.USD","LU1119994496.HKD","SGXZ23171101.USD","SG9999004303.SGD","BK4084","BK4585","LU2324357040.USD"],"gpt_icon":0},{"id":"2482440866","title":"Cencora's (NYSE:COR) Dividend Will Be Increased To $0.55","url":"https://stock-news.laohu8.com/highlight/detail?id=2482440866","media":"Simply Wall St.","labels":["Shareholding Changes"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2482440866?lang=en_us&edition=fundamental","pubTime":"2024-11-09 20:02","pubTimestamp":1731153765,"startTime":"0","endTime":"0","summary":"Cencora, Inc.'s  dividend will be increasing from last year's payment of the same period to $0.55 on 29th of November. Despite this raise, the dividend yield of 0.9% is only a modest boost to shareholder returns.Cencora's Payment Could Potentially Have Solid Earnings Coverage. If it is predictable over a long period, even low dividend yields can be attractive. However, prior to this announcement, Cencora's dividend was comfortably covered by both cash flow and earnings. This means that most of its earnings are being retained to grow the business.Looking forward, earnings per share is forecast to rise by 107.6% over the next year. If the dividend continues on this path, the payout ratio could be 14% by next year, which we think can be pretty sustainable going forward.","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/mqTkKyjDNcFqvOf.wSUauQ--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/0d420881cf99e8229dddbfddf7bc7ebf","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/mqTkKyjDNcFqvOf.wSUauQ--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/0d420881cf99e8229dddbfddf7bc7ebf"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/cencoras-nyse-cor-dividend-increased-120245232.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"Shareholding Changes","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4585","BK4175","LU1261432733.SGD","LU0289739699.SGD","LU1585245621.USD","BK4529","NYSE","CAGR","LU1084165304.USD","COR","LU1119994496.HKD","LU1430594728.SGD","BK4159","BK4588","SGXZ23171101.USD","LU2324357040.USD","SG9999004303.SGD","LU0058720904.USD","BK4084"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.cencora.com","stockEarnings":[{"period":"1week","weight":0.0094},{"period":"1month","weight":0.0492},{"period":"3month","weight":0.0334},{"period":"6month","weight":0.1224},{"period":"1year","weight":0.2304},{"period":"ytd","weight":0.1963}],"compareEarnings":[{"period":"1week","weight":0.0005},{"period":"1month","weight":0.0177},{"period":"3month","weight":0.0561},{"period":"6month","weight":0.1213},{"period":"1year","weight":0.3047},{"period":"ytd","weight":0.249}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"","yearOnYearQuotes":[{"month":1,"riseRate":0.785714,"avgChangeRate":0.046624},{"month":2,"riseRate":0.571429,"avgChangeRate":-0.002446},{"month":3,"riseRate":0.571429,"avgChangeRate":0.006015},{"month":4,"riseRate":0.571429,"avgChangeRate":0.015087},{"month":5,"riseRate":0.642857,"avgChangeRate":0.025214},{"month":6,"riseRate":0.517241,"avgChangeRate":0.029089},{"month":7,"riseRate":0.586207,"avgChangeRate":0.014597},{"month":8,"riseRate":0.586207,"avgChangeRate":-0.010675},{"month":9,"riseRate":0.517241,"avgChangeRate":0.023105},{"month":10,"riseRate":0.551724,"avgChangeRate":-0.00923},{"month":11,"riseRate":0.689655,"avgChangeRate":0.029856},{"month":12,"riseRate":0.571429,"avgChangeRate":0.021519}],"exchange":"NYSE","name":"Cencora Inc.","nameEN":"Cencora Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.29.2","shortVersion":"4.29.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Cencora Inc.(COR),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Cencora Inc.(COR) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Cencora Inc.,COR,Cencora Inc.股票,Cencora Inc.股票老虎,Cencora Inc.股票老虎国际,Cencora Inc.行情,Cencora Inc.股票行情,Cencora Inc.股价,Cencora Inc.股市,Cencora Inc.股票价格,Cencora Inc.股票交易,Cencora Inc.股票购买,Cencora Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Cencora Inc.(COR),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Cencora Inc.(COR) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction